K091559 · Chestnut Medical Technologies, Inc. · KRA · Sep 18, 2009 · Cardiovascular
Device Facts
Record ID
K091559
Device Name
MARKSMANN CATHETER
Applicant
Chestnut Medical Technologies, Inc.
Product Code
KRA · Cardiovascular
Decision Date
Sep 18, 2009
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.1210
Device Class
Class 2
Intended Use
The Marksman™ Catheter is intended for the introduction of interventional devices and infusion of diagnostic or therapeutic agents into the neuro, peripheral and coronary vasculature.
Device Story
Marksman™ Catheter is a variable stiffness, single-lumen catheter for accessing small, tortuous vascular areas. It features a hydrophilic-coated distal segment for lubricity, a PTFE liner to facilitate device movement, and a radiopaque distal tip for fluoroscopic visualization. The distal tip is shapeable. Used by physicians in clinical settings to introduce interventional devices (e.g., embolic agents, coils, stents) or infuse diagnostic/therapeutic agents into neuro, peripheral, and coronary vasculature. The device is single-use only.
Clinical Evidence
Clinical evaluation was conducted in neurovascular anatomy, considered the worst-case representation of cardiac and peripheral vascular anatomies, to demonstrate that no new risks were identified and the safety and effectiveness profile is similar to well-established predicate devices.
Technological Characteristics
Variable stiffness, single-lumen catheter. Materials include PTFE liner and hydrophilic coating. Radiopaque distal tip. Sterilized via Ethylene Oxide per ISO 11135. No electronic components or software.
Indications for Use
Indicated for patients requiring introduction of interventional devices or infusion of diagnostic/therapeutic agents into neuro, peripheral, and coronary vasculature.
Regulatory Classification
Identification
A continuous flush catheter is an attachment to a catheter-transducer system that permits continuous intravascular flushing at a slow infusion rate for the purpose of eliminating clotting, back-leakage, and waveform damping.
Related Devices
K111490 — MARKSMAN CATHETER, *REFERS TO DIFFERENT CATHETER WORKING LENGHTS, DISTAL SINGLE COILED LENGTHS AND DISTAL SHAFT LENGTHS · Ev3, Inc. · Sep 16, 2011
K070279 — MODIFICATION TO HYPERTRANSIT INFUSION CATHETER · Cordis Neurovascular, Inc. · Mar 14, 2007
K151638 — Phenom 17 Catheter, Phenom 21 Catheter, Phenom 27 Catheter, Phenom Plus Catheter · Cathera, Inc. · Nov 13, 2015
K252569 — Carrier XL Delivery Catheter · Balt USA, LLC · Oct 22, 2025
K230609 — NG Delivery Catheter · Balt USA, LLC · Sep 13, 2023
Submission Summary (Full Text)
{0}------------------------------------------------
# 5. 510(k) Summary
# SUMMARY OF SAFETY AND EFFECTIVENESS
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92(c).
# Submitted by:
Chestnut Medical Technologies, Inc. 173 Jefferson Drive Menlo Park, CA 94025 Tel .: (650) 566-0057 Fax: (650) 566-0072
Contact Person: Daniel Cher, M.D.
Date summary prepared: May 27, 2009
Trade Name: Marksman™ Catheter
Common Name: Catheter
Classification Name: Catheter, Continuous Flush (21 CFR 870.1210, Product Code KRA)
## Device Description:
The Marksman™ Catheter is a variable stiffness, single lumen catheter designed to access small, tortuous vascular areas. The outer surface of the catheter's distal segment is coated with a hydrophilic material to provide lubricity during use. The catheter also incorporates a PTFE liner to facilitate movement of introduction devices passed through its lumen. The Marksman™ Catheter has a radiopaque marker at the distal tip to facilitate fluoroscopic visualization. The distal tip of the catheter is shapeable. The Marksman™ Catheter is provided with various working lengths. The Marksman™ Catheter is for single use only.
## Indications for Use:
The Marksman™ Catheter is intended for the introduction of interventional devices and infusion of diagnostic or therapeutic agents into the neuro, peripheral and coronary vasculature.
## Marksman Catheter
# CONFIDENTIAL
{1}------------------------------------------------
#### Substantial Equivalence Determination
The information presented in the 510k shows that the Marksman™ Catheter is substantially equivalent to predicate endovascular catheters in regards to the following aspects:
Design:
The subject and predicate devices are substantially equivalent with respect to design characteristics. The slight variations in flexibility, length of coated segments and lubricity are what differentiate these catheters. Each manufacturer optimizes these design variations towards a more specific application (e.g. infusion of diagnostic and therapeutic agents) or for the introduction of a specific devices such as embolic agents, coils and stents.
Function:
The subject and predicate devices are substantially equivalent with respect to functional characteristics.
Manufacturing: The subject and predicate devices are similar with respect to
Materials:
Indications:
Packaging:
technological manufacturing processes.
The subject and predicate devices are composed of similar materials, all of which have an extensive clinical history of safe use in medical devices.
The subject and predicate devices maintain similar indications.
The subject and predicate devices utilize similar packaging configurations.
Sterilization:
The subject and predicate devices are both sterilized utilizing a Ethylene Oxide sterilization cycle validated in accordance with ISO 11135 - Medical Devices - Validation and Routine Control of Ethylene Oxide Sterilization.
Labeling:
Both the subject and predicate devices have similar labeling.
Clinical evaluation was conducted to show that no new risks were identified and that the . safety and effectiveness profile is similar to well-established predicate devices cleared for the market. Evaluation was performed in the more complex and higher risk neurovascular anatomy, which is the worst case representation of the cardiac and peripheral vascular anatomies.
Marksman Catheter
## CONFIDENTIAL
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its wing. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle.
SEP 1 8 2009
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-0609 Silver Spring, MD 20993-0002
Chestnut Medical Technologies, Inc. 1 C/O Daniel Cher, M.D. 173 Jefferson Dr. Menlo Park, CA 94025
Re: K091559
Trade/Device Name: Marksman™M Catheter Regulation Number: 21 CFR 870,1210 Regulation Name: Catheter, Continuous Flush Regulatory Class: Class II Product Code: KRA Dated: September 10, 2009 Received: September 11, 2009
Dear Dr. Cher:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
{3}------------------------------------------------
Page 2 - Daniel Cher, M.D.
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Duma R. V. Achmer
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use
510(k) Number (if known): K091559
Device Name: Marksman™ Catheter.
Indications for Use:
The Marksman™ Catheter is intended for the introduction of interventional devices and infusion of diagnostic or therapeutic agents into the neuro, peripheral and coronary vasculature.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
> Concurrence of CDRH, Office of Device Evaluation (ODE) oursel & pilmit
> > CONFIDENTIAL
(Division Sign Off) Division of Cardionascular Devices
510(K) Number_KO91559
Page 1 of 1
Marksman Catheter
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.